EUVIMEDEUVIMED entdecken
Crossref

Pharmacognostic, Pharmacological And Nanotechnological Perspectives Of D-Limonene-Rich Citrus Pyriformis Peel Oil

Sakshi Dudhane, Vipul Patil, Omkar Gouraje, Yogita Sutar, Prathamesh Gurav, Atharv Shinde, Sapana Gawari

International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)

DOI: 10.25258/ijddt.16.43s.29 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Sakshi Dudhane und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Citrus genus is a family Rutaceae that consists of over 160 species of great nutritional, medicinal and economic value. Some of these species include Citrus pyriformis (ponderosa lemon) that has large fruits with gummy peel cavities that are a significant source of essential oils. These oils are mostly mono- and sesquiterpenes with D-limonene as the most prominent bioactive molecule commonly used in the food, pharmaceutical, cosmetics, and aromatherapy sectors -limonene is considered mostly safe and easily broken down to excretable molecules. It presents variety of pharmacological effects which are the antioxidant, antimicrobial, antiflammatory, cardio protection, gastro protection, neuro-protection, anticancer, antiviral, and insecticidal effects. These biological processes are mainly facilitated by control of oxidative stress, inflammatory signalling pathways, microbial growth and apoptosis. Nevertheless, its practical use is hampered by solubility difficulties in water, hydrophobicity, volatility and oxidative degradation. The recent developments in nanotechnology based delivery systems like Nano emulsions, microencapsulation and polymeric fibre formulations have shown a great potential of improving its stability, bioavailability and controlled release. In general, this review outlines pharmacological characteristics and therapeutic target of D-limonene extracted out of Citrus pyriformis and highlights the role of optimal formulation techniques and combination therapy in enhancing its clinical and industrial potential. More toxicological and pharmacokinetic research desires to be conducted in order to be able to use it safely and effectively as a therapeutic agent.

Zitieren

APA

Dudhane, S., Patil, V., Gouraje, O., Sutar, Y., Gurav, P., Shinde, A., & Gawari, S. (2026). Pharmacognostic, Pharmacological And Nanotechnological Perspectives Of D-Limonene-Rich Citrus Pyriformis Peel Oil. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.29

Vancouver

Dudhane S, Patil V, Gouraje O, Sutar Y, Gurav P, Shinde A, et al. Pharmacognostic, Pharmacological And Nanotechnological Perspectives Of D-Limonene-Rich Citrus Pyriformis Peel Oil. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.29

BibTeX
@article{Dudhane2026,
  author = {Dudhane, Sakshi and Patil, Vipul and Gouraje, Omkar and Sutar, Yogita and Gurav, Prathamesh and Shinde, Atharv and Gawari, Sapana},
  title = {Pharmacognostic, Pharmacological And Nanotechnological Perspectives Of D-Limonene-Rich Citrus Pyriformis Peel Oil},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {43s},
  doi = {10.25258/ijddt.16.43s.29}
}
Kostenlos starten →